DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cancidas (Caspofungin) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (127)
Death (71)
Life Threatening Events (20)

Reports by Reaction Type

Drug Ineffective (27)Septic Shock (18)Death (16)Renal Failure Acute (15)Drug Interaction (10)Overdose (9)Hepatic Failure (6)Multiple Drug Overdose (6)Hypersensitivity (5)Hepatotoxicity (5)Hypotension (5)Respiratory Distress (5)

Below are a few examples of reports where side effects / adverse reactions may be related to Cancidas (Caspofungin). For a complete list or a specific selection of reports, please use the links above.

Possible Cancidas side effects in

Reported by a physician from France on 2012-08-23

Patient:

Reactions: Death, Cytolytic Hepatitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ambisome
    Dosage: 250 mg, qd
    Indication: Systemic Candida
    Start date: 2012-04-08
    End date: 2012-04-22

Cancidas
    Dosage: 70 mg, qd
    Start date: 2012-03-22
    End date: 2012-04-08

Cancidas
    Dosage: 70 mg, qd
    Indication: Systemic Candida
    Start date: 2012-04-20
    End date: 2012-04-22

Tienam IV
    Dosage: 500 mg, q6h
    Indication: Septic Shock
    Start date: 2012-04-18
    End date: 2012-04-22

Other drugs received by patient: Magnesium Sulfate; Targocid; Nexium; Norepinephrine; Fosfomycin



Possible Cancidas side effects in

Reported by a consumer/non-health professional from Netherlands on 2012-08-15

Patient:

Reactions: Hyperkalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cancidas
    Dosage: 50 mg, qd
    Start date: 2010-01-28
    End date: 2010-02-16

Cancidas
    Dosage: 70 mg, qd
    Indication: Infection Prophylaxis
    Start date: 2010-01-27
    End date: 2010-01-27

Tacrolimus
    Indication: Liver Transplant
    Start date: 2009-05-25
    End date: 2010-01-27

Tacrolimus
    Indication: Immunosuppression
    Start date: 2010-01-29
    End date: 2010-03-09

Tacrolimus
    Start date: 2010-03-10
    End date: 2010-03-14

Tacrolimus
    Start date: 2010-03-17

Vancomycin
    Indication: Localised Intraabdominal Fluid Collection
    Start date: 2010-01-26
    End date: 2010-02-04

Vancomycin
    Indication: Staphylococcal Infection

Other drugs received by patient: Norfloxacin; Esomeprazole; Albumin (Human); Methylprednisolone; Insulin; Ipratropium Bromide; Plasma Protein Fraction (Human); Plasma Protein Fraction (Human); Sulfamethoxazole and Trimethoprim; Mycophenolate Mofetil; Terlipressin; Insulin; Meropenem; Blood Cells, RED; Omeprazole; Omeprazole; Heparin; Insulin; Dextrose; Duovent; Ceftriaxone Sodium; Ursodiol; Methylprednisolone; Acyclovir; Duovent; Mycophenolate Mofetil; Esomeprazole; Magnesium Sulfate; Lactitol; Albumin (Human); Ampicillin; Norepinephrine; Tramadol Hydrochloride; Heparin



Possible Cancidas side effects in

Reported by a pharmacist from United States on 2012-08-15

Patient:

Reactions: Blood Phosphorus Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cancidas

Other drugs received by patient: Ativan; Methotrexate; Mercaptopurine; Lithium Carbonate; Scopolamine; Bactrim; Melatonin; Clonidine; Prevacid; Norvasc; Marinol; Lovenox; Acetaminophen / Hydrocodone Bitartrate; Leucovorin Calcium; Potassium (Unspecified); Zofran; Morphine



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-07

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Other drugs received by patient possibly interacting with the suspect drug:
Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin HCL
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Other drugs received by patient: Colistin; Gentamicin; Neupogen



Possible Cancidas side effects in 15 year old female

Reported by a individual with unspecified qualification from Ireland on 2012-08-06

Patient: 15 year old female

Reactions: Nephropathy Toxic, Drug Interaction, Multiple Drug Overdose, Respiratory Distress, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cancidas
    Dosage: ; iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Cyclosporine
    Dosage: 200 mg; ;po
    Administration route: Oral
    Indication: Aplasia
    Start date: 2012-04-23
    End date: 2012-05-31

Gentamicin
    Dosage: 170 ug; ;iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
    Dosage: ; iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-01

Trimethoprim + Sulfamethoxazole
    Dosage: ; tid; iv
    Indication: Prophylaxis
    Start date: 2012-04-01

Vancomycin
    Dosage: 2 gm; iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22

Voriconazole
    Dosage: ; iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Atgam; Ciprofloxacin; Filgrastim



Possible Cancidas side effects in

Reported by a physician from United States on 2012-08-03

Patient:

Reactions: Drug Ineffective

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cancidas
    Indication: Oesophagitis

Cancidas
    Indication: Oropharyngeal Candidiasis

Other drugs received by patient: Lamivudine; Abacavir Sulfate; Raltegravir; Sulfamethoxazole and Trimethoprim; Etravirine



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin HCL
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Colistin; Neupogen; Gentamicin



Possible Cancidas side effects in

Reported by a physician from United States on 2012-08-01

Patient:

Reactions: Pneumonia Bacterial, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cancidas

Other drugs received by patient: Voriconazole



Possible Cancidas side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient:

Reactions: Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, tiw
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, bid
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 2250 mg, qd
    Start date: 2012-05-01
    End date: 2012-05-01

Vancomycin
    Dosage: 2000 mg, qd
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22
    End date: 2012-05-01

Vancomycin
    Dosage: 1800 mg, qd
    Start date: 2012-05-01
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2012-05-26
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Neupogen



Possible Cancidas side effects in female

Reported by a physician from France on 2012-07-27

Patient: female

Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1unit three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-01

Gentamicin
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100mg twice per day
    Administration route: Oral
    Indication: Aplasia
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 1g twice per day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22

Vfend
    Dosage: 200mg twice per day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Atgam; Colistine; Neupogen



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: 15 year old female

Reactions: Drug Interaction, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas
    Dosage: iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-04

Cyclosporine
    Dosage: 200 mg;po
    Administration route: Oral
    Indication: Aplasia
    Start date: 2012-04-23
    End date: 2012-05-31

Gentamicin
    Dosage: 170 ug;iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
    Dosage: iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-01

Trimethoprim + Sulfamethoxazole
    Dosage: tid;iv
    Indication: Prophylaxis
    Start date: 2012-04-01

Vancomycin
    Dosage: 2 gm;iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22

Voriconazole
    Dosage: 400 mg;iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Filgrastim; Colistin; Atgam



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Hepatic Failure, Drug Interaction, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient:

Reactions: Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, tiw
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, bid
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 2250 mg, qd
    Start date: 2012-05-01
    End date: 2012-05-01

Vancomycin
    Dosage: 1800 mg, qd
    Start date: 2012-05-01
    End date: 2012-06-03

Vancomycin
    Dosage: 1000 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22
    End date: 2012-05-01

Vfend
    Dosage: 200 mg, bid
    Start date: 2012-05-14
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Neupogen



Possible Cancidas side effects in female

Reported by a physician from France on 2012-07-20

Patient: female

Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1unit three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-01

Gentamicin
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100mg twice per day
    Administration route: Oral
    Indication: Aplasia
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 1g twice per day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22

Vfend
    Dosage: 200mg twice per day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Atgam; Colistine; Neupogen



Possible Cancidas side effects in

Reported by a physician from United States on 2012-07-20

Patient:

Reactions: Pneumonia Bacterial, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cancidas

Other drugs received by patient: Voriconazole



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Other drugs received by patient: Neupogen; Colistin; Gentamicin



Possible Cancidas side effects in 27 year old female

Reported by a individual with unspecified qualification from France on 2012-07-17

Patient: 27 year old female

Reactions: Anaphylactic Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cancidas
    Dosage: 70.00 mg
    Indication: Candidiasis
    Start date: 2012-02-10
    End date: 2012-02-10

Foscavir
    Dosage: intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-10
    End date: 2012-02-10

Other drugs received by patient: Gaviscon; Truvada; Lederfoline( Lederfoline); Raltegravir (Raltegravir); Inexium (Inexium); Fluconazole; Diffu K (Diffu K); Bactrim; Primperan (Primperan); Rovalcyte (Rovalcyte)



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-16

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Vfend
    Administration route: Oral

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in 75 year old male

Reported by a physician from United States on 2012-07-02

Patient: 75 year old male

Reactions: Pneumonia Bacterial, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cancidas

Other drugs received by patient: Voriconazole



Possible Cancidas side effects in female

Reported by a physician from Japan on 2012-06-19

Patient: female

Reactions: Respiratory Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas



Possible Cancidas side effects in male

Reported by a physician from France on 2012-06-14

Patient: male

Reactions: Drug Ineffective, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas



Possible Cancidas side effects in male

Reported by a physician from France on 2012-06-14

Patient: male

Reactions: Drug Ineffective, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas



Possible Cancidas side effects in 69 year old male

Reported by a physician from Spain on 2012-06-14

Patient: 69 year old male

Reactions: Drug Resistance, Treatment Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cancidas
    Indication: Candidiasis
    Start date: 2009-06-26
    End date: 2009-06-26

Cancidas
    Start date: 2009-06-27
    End date: 2009-07-25

Cancidas
    Start date: 2009-08-01
    End date: 2009-09-01



Possible Cancidas side effects in female

Reported by a physician from France on 2012-06-14

Patient: female

Reactions: Drug Ineffective, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas



Possible Cancidas side effects in 14 year old male

Reported by a physician from Spain on 2012-06-04

Patient: 14 year old male

Reactions: Respiratory Disorder, Anaphylactic Reaction, Subcutaneous Emphysema, Acidosis, Pyrexia, Transaminases Increased, Weight Increased, Cardio-Respiratory Arrest, Hepatotoxicity, Simplex Virus Test Positive, Decubitus Ulcer, Graft Versus Host Disease in Skin, Pneumothorax, Intracranial Pressure Increased, Escherichia Sepsis, Bone Marrow Transplant, Clostridium Test Positive, Hypotension, Complications of Bone Marrow Transplant, Respiratory Distress, Aplasia, Renal Failure, Fungal Test Positive, Hypoproteinaemia, Bradycardia, Staphylococcus Test Positive

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas
    Dosage: iv
    Indication: Aspergillosis
    Start date: 2010-12-01
    End date: 2011-03-01

Cancidas
    Dosage: iv
    Indication: Rhinitis
    Start date: 2010-12-01
    End date: 2011-03-01

Voriconazole
    Dosage: iv
    Indication: Prophylaxis

Other drugs received by patient: Cyclophosphamide; Amphotericin B (+) Cholesterol (+) Diste



Possible Cancidas side effects in male

Reported by a physician from France on 2012-06-01

Patient: male

Reactions: Death, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas



Possible Cancidas side effects in male

Reported by a physician from France on 2012-06-01

Patient: male

Reactions: Death, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas



Possible Cancidas side effects in female

Reported by a physician from France on 2012-06-01

Patient: female

Reactions: Death, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017